MEDICATED TOPICAL SOLUTION HYDROGEL

Brand Owner (click to sort) Address Description
ALEVICYN Oculus Innovative Sciences, Inc. 1129 North McDowell Blvd. Petaluma CA 94954 Medicated topical solution and hydrogel preparations for the relief of pain, burning and itching associated with dermatoses;
ALUVICYN SONOMA PHARMACEUTICALS, INC. Suite 150 5445 Conestoga Court Boulder CO 80301 Medicated topical solution and hydrogel preparations for the relief of pain, burning and itching associated with dermatoses;
LEVICYN SONOMA PHARMACEUTICALS, INC. Suite 150 5445 Conestoga Court Boulder CO 80301 Medicated topical solution and hydrogel preparations for the relief of pain, burning and itching associated with dermatoses;
PEDIACYN SONOMA PHARMACEUTICALS, INC. Suite 150 5445 Conestoga Court Boulder CO 80301 Medicated topical solution and hydrogel preparations for the relief of pain, burning and itching associated with dermatoses;
PEDIACYN SONOMA PHARMACEUTICALS, INC. Suite 150 5445 Conestoga Court Boulder CO 80301 Medicated topical solution and hydrogel for use in connection with, cleansing, irrigation, moistening, debridement and removal of foreign material from wounds and dermal lesions; treatment of stage I-IV pressure ulcers, stasis ulcers, diabetic ulcers, post-surgical wounds, first-and-second-degree burns, abrasions, minor irritations of the skin, diabetic foot ulcers, ingrown toe nails, grafted and donor skin sites and exit skin sites; moistening and lubricating wound dressings and irrigation of wounds; relief and treatment of pain for burns, exuding wounds, mechanically or surgically debrided wounds; relief and moistening of dry waxy skin;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method for encapsulating biologics within a hydrogel by using an aqueous solution of an isocyanate-functional hydrogel prepolymer which is mixed with an amount of biologics and an aqueous solution containing a dithiol crosslinking agent under physiological pH conditions. An additional bidentate crosslinking agent may be included. The product of such method may be a bioreactor or an assay device having a plurality or different biologics encapsulated at predetermined locations in a substrate.